Aesthetics Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Log In

Individualized Management of Patients with Dry Eye Disease: Webinar 1

By: Christophe Baudouin, MD, PhD, FARVO; Elisabeth M. Messmer, MD, FEBO

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

Expiration Date: Wednesday, September 18, 2019
Release Date: September 17, 2018

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss the mechanism of action of dry eye disease.
  • Evaluate the signs and symptoms in patients with dry eye complaints.
  • Discuss the prevalence of dry eye disease.
  • Develop a differential diagnosis for patients with complaints of dry eye.

Accreditation and Designation Statement

The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the European Union of Medical Specialties (UEMS). Following the agreement on the mutual recognition of credits between the AMA and the UEMS-European Accreditation Council for CME, European physicians can earn ECMECs® by completing e-learning programs from accredited providers that have been certified for AMA PRA Category 1 Credits™.
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Disclosures

Professor Christophe Baudouin, MD, PhD, FARVO,
has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Alcon, Dompe, Horus Pharma, Shire, Santen, and Thèa. Grant/Research Support: Horus Pharma, Santen, and Thèa.

Professor Elisabeth Messmer, MD, FEBO,
has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon/Novartis, Allergan, Dompe, Santen, Shire, Thèa, TRB-Chemedica, and Visufarma. Advisory Board/Speaker’s Bureau: Alcon/Novartis, Dompe, Santen, Shire, Thèa, TRB-Chemedica, and Visufarma. Grant/Research Support: Sylentis and Ursapharm.

Editorial Support Disclosure
Michelle Dalton, Writer, Susan Gallagher-Pecha, director of client services and project management, Evolve Medical Education LLC, and Erin Fletcher, MIT, director of compliance and education, Evolve Medical Education LLC, have no real or apparent conflicts of interest to report. Jaya Kumar, MD, peer reviewer has no conflict of interest to report.


This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Shire.

Video Resources